ACE2 has also been shown to inhibit tumor cell growth, metastasis, and angiogenesis in laryngeal, lung, gallbladder, and pancreatic cancers, as well as osteosarcoma [56]. This evidence concerns the gene ACE2 and pancreatic neoplasm.